Elevance Health
1,667 hedge funds and large institutions have $107B invested in Elevance Health in 2024 Q1 according to their latest regulatory filings, with 156 funds opening new positions, 671 increasing their positions, 547 reducing their positions, and 121 closing their positions.
29% more first-time investments, than exits
New positions opened: 156 | Existing positions closed: 121
23% more repeat investments, than reductions
Existing positions increased: 671 | Existing positions reduced: 547
8% more capital invested
Capital invested by funds: $99.5B → $107B (+$7.95B)
6% more funds holding in top 10
Funds holding in top 10: 49 → 52 (+3)
2% more call options, than puts
Call options by funds: $687M | Put options by funds: $673M
1% more funds holding
Funds holding: 1,656 → 1,667 (+11)
0.63% less ownership
Funds ownership: 89.78% → 89.15% (-0.63%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$273M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$270M |
| 3 |
Holocene Advisors
New York
|
+$211M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$189M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$163M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.42B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$702M |
| 3 |
Renaissance Technologies
New York
|
-$181M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$180M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$152M |
ELV Hedge Fund Activity: Q1 2024 in Review
1,667 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q1 2024, worth a combined $107B — up 8% from $99.5B a quarter earlier.
Buyers outnumbered sellers: 156 funds opened new ELV positions and 121 closed out — a net gain of 35 holders — while 671 added to existing stakes and 547 trimmed.
The largest buyer was Massachusetts Financial Services, adding an estimated $273M. The largest seller was Morgan Stanley, cutting an estimated $1.42B.
- 1,667 institutional investors held Elevance Health (ELV) as of Q1 2024, up from 1,656 in Q4 2023.
- Funds reported $107B of Elevance Health stock for Q1 2024, up 8% quarter-over-quarter.
- 156 funds opened new Elevance Health positions in Q1 2024 and 121 closed out, a net change of +35 holders.
- The largest Elevance Health buyer in Q1 2024 was Massachusetts Financial Services, an estimated $273M added.
- The largest Elevance Health seller in Q1 2024 was Morgan Stanley, an estimated $1.42B sold.
Based on aggregated 13F filings for Q1 2024.